Latest Headlines

  1. WuXi Biologics Commenced Construction Of A 48,000 L Integrated Manufacturing Center For Innovative Biologics In Chengdu

    WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that the construction of a new 1.3 million sq. ft. integrated manufacturing center for innovative biologics has commenced in Chengdu, one of the largest cities in Southwest China.

  2. Thermo Fisher Scientific To Acquire Manufacturing Site In Cork, Ireland, From GSK
  3. Biopharmaceutical Manufacturers Offered A Guiding Hand In Filtration Process Optimization

    Biopharmaceutical manufacturers will be supported in guaranteeing product quality and reducing costs, through an upcoming webinar to be delivered by Parker Bioscience Filtration.

  4. Bayer Invests $150M To Build New Cell Culture Technology Center In Berkeley To Spur Innovation Of Biotech Therapies

    Bayer announced today it will invest $150 million in its Berkeley, CApharmaceutical development and manufacturing site to build a Cell Culture Technology Center that will be used to accelerate the development of biological therapies.

  5. Sartorius Stedim Biotech Introduces New SIMCA® 16 Software For Multivariate Data Analytics

    Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry recently announced the new SIMCA® 16 software for multivariate data analytics is available from its subsidiary Sartorius Stedim Data Analytics.

  6. Sartorius Stedim Biotech Launches New ambr® 15 Cell Culture Microbioreactor System

    Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry, is introducing its new generation of ambr® 15 cell culture automated microbioreactor system. The Generation 2 is the successor to the well-established ambr® 15 cell culture system, proven in the industry to significantly reduce cell line development timelines and increase lab productivity. The new system offers increased flexibility and expanded capability for clone selection, media and feed optimization and early process development work.

  7. Thermo Fisher Scientific Completes Acquisition Of Brammer Bio

    Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has completed its previously announced acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for approximately $1.7 billion in cash.  The completion of the transaction follows the receipt of all required regulatory approvals.

  8. From The Transfection Experts: Obtain Industry-Leading Protein Yields With The New CHOgro High Yield Expression System

    Researchers now have an opportunity to achieve higher protein yields from transient transfection of suspension CHO cells.

  9. Automated Evaporative Sample Preparation For Clinical Biochemistry

    SP Scientific’s Genevac EZ-2 Centrifugal Evaporator is providing the Clinical Biochemistry department at a leading UK hospital with a reliable, easy-to-use method of preparing clinical samples ready for testing.

  10. Protecting Vacuum Pumps & Equipment From Corrosive Vapors

    SP Scientific has introduced a new and updated Vapor Trap - a next generation cold trap for protecting oil-sealed vacuum pumps, evaporators and dryers from corrosive and harmful vapors that may shorten operating lifetime.